APOE and Alzheimer disease: Additionally, the replication cohort also included a few atypical AD participants with highly elevated CSF t-tau levels (Pillai et al., 2019a) and had a higher frequency of APOE ε4 carriers, unlike typical amnestic MCI participants in the ADNI cohort.